Gains beyond all expectations. Even the most favorable projections could barely come up with these levels. COVID VACCINE STOCKS have been on amazing run - far exceeding the peaks of this past July. Now there are companies on this list dealing with supply shortages for a literal global market and governments who can print seemingly unending amounts of money desperately trying to get as much product as possible.
The issue of COVID variants has sprung on the scene. This means that many of these companies are potentially in play for massive gains.
The one exception to this is the apparent flame out of Vaxart which rocketed up then down this past week, making only a one week stay in the TOP TEN.
This week Translate Bio and PDS Bio made moves into the TOP TEN, displacing the aforementioned VXRT and also BioNTech which was flat for the week, which is not good enough to maintain your place in a market like this.
Overall, returns for all 27 is now had the highest level ever: 262%.
Novavax has distorted everything with its ridiculous outsize gains - now with 1714% return since March 1. Moderna is next at 580%.
No comments:
Post a Comment